Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine

Agriculture & Biology

• cancer vaccines 100%
• phosphatidylserines 63%
• interleukin-2 61%
• breast neoplasms 61%
• antibodies 35%
• immunosuppressive agents 31%
• mice 31%
• vaccines 30%
• metastasis 22%
• splenocytes 19%
• cells 17%
• neoplasm cells 16%
• coatings 14%
• neoplasms 13%
• dendritic cells 11%
• immunogenicity 10%
• interferon-gamma 10%
• cell membranes 7%
• cytotoxicity 7%
• phospholipids 7%
• lungs 7%
• plasma membrane 7%
• incidence 6%

Medicine & Life Sciences

• Cancer Vaccines 65%
• Phosphatidylserines 61%
• Interleukin-2 47%
• Breast Neoplasms 34%
• Antibodies 29%
• Vaccines 14%
• Immunosuppressive Agents 12%
• Cell Membrane 7%
• mouse IFNG protein 6%
• Neoplasms 6%
• Neoplasm Metastasis 6%
• Phospholipids 4%
• Dendritic Cells 4%
• Recurrence 2%
• Survival 2%
• Control Groups 2%
• Lung 2%
• Growth 2%
• Incidence 2%
• Therapeutics 0%

Social Sciences

• Group 16%
• leaflet 10%
• treatment modalities 10%
• incidence 6%